Publication Name	World Journal of Hepatology
Manuscript ID	32203
Country	Australia

Received	2016-12-29 14:48
Peer-Review Started	2016-12-29 16:45
To Make the First Decision	2017-02-04 14:27
Return for Revision	2017-02-08 13:10
Revised	2017-03-06 11:59
Second Decision	2017-04-12 18:33
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-04-24 10:27
Articles in Press	2017-04-24 10:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-27 08:05
Publish the Manuscript Online	2017-06-14 07:52

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
Manuscript Source	Invited Conference Manuscripts
All Author List	Stephanie Wong, Dep Huynh, Frank Zhang and Nam Q Nguyen
Funding Agency and Grant Number
Corresponding Author	Nam Q Nguyen, Associate Professor, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, North Terrace, Adelaide 5000, Australia. quocnam.nguyen@sa.gov.au
Key Words	Liver fibrosis; Aspartate aminotransferase to platelet ratio; Utilization; FibroScan
Core Tip	This is the first study to show that an aspartate aminotransferase to platelet ratio (APRI) score of 0.5 could potentially be used as a screening tool to predict the need for FibroScan in patients with hepatitis C or hepatitis B. Our study showed that an APRI score of 0.5 could reduce the need for FibroScan in 43% of the study cohort with high sensitivity.
Publish Date	2017-06-14 07:52
Citation	Wong S, Huynh D, Zhang F, Nguyen NQ. Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis. World J Hepatol 2017; 9(17): 791-796
URL	http://www.wjgnet.com/1948-5182/full/v9/i17/791.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i17.791

Full Article (PDF)	WJH-9-791.pdf
Full Article (Word)	WJH-9-791.doc
Manuscript File	32203-Review.docx
Answering Reviewers	32203-Answering reviewers.pdf
Audio Core Tip	32203-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	32203-Conflict-of-interest statement.pdf
Copyright License Agreement	32203-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	32203-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	32203-Institutional review board statement.pdf
Peer-review Report	32203-Peer-review(s).pdf
Scientific Misconduct Check	32203-Scientific misconduct check.pdf
Scientific Editor Work List	32203-Scientific editor work list.pdf